Longitudinal assessment of angiogenic markers in prediction of adverse outcome in women with confirmed pre-eclampsia.

Longitudinal maternal serum angiogenic marker assessment is a good predictor of adverse maternal and perinatal outcomes and superior to some of the conventional laboratory parameters in pregnancies with pre-eclampsia. More studies should focus on the optimal surveillance following the diagnosis of pre-eclampsia. This article is protected by copyright. All rights reserved.